Possible risk of particles in the solution for injection

Possible impact on sterility because of loose caps

Recall of a batch of Norocarp due to a deviation during stability monitoring analysis.

Recall due to unidentified impurities.

Recall of a batch of Norocarp due to a deviation during stability monitoring analysis.

Effectiveness cannot be guaranteed.

Incorrect designation of the medicinal product on one side of the outer packaging.

The BASG was alerted to an incident in Denmark where Porcine Reproductive and Respiratory Syndrome (PRRS) had broken out in PRRS-negative pig herds.

"Richter Pharma AG" has informed its customers on November 22, 2019 that the below mentioned batch of "Ivertin" will be recalled due to a possible reduced content of Ivermectin, which results from a deficiency of the vials.

The marketing authorisation holder and its distribution partner informed their customers on March 25, 2019 that particles had been detected in individual batches.